Top compounds associated with response to CBLL1


Feature Type Standardized
Nominal ANOVA
mRNA Sorafenib FIMM pan-cancer AAC -0.073 0.7
mRNA PFI-1 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.021 0.7
mRNA XMD14-99 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA GNF-2 GDSC1000 pan-cancer AAC 0.023 0.7
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.014 0.7
mRNA BRD-K51831558 CTRPv2 pan-cancer AAC 0.022 0.7
mRNA Dasatinib GDSC1000 pan-cancer AAC 0.022 0.7
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC -0.032 0.7
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
Download CSV